Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-039725

Chief Medical Officer sold 7,700 shares at $0.85 ($6,507)

From the SEC's structured data for this filing

Trades in this filing

Bahrt Kenneth · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-06-25 Sale : show line 1 in the form −7,700 $0.85 $6,507 47,120 D
Open-market sales · 7,700 sh · avg $0.85 · $6,507
Loading xslF345X03/doc4.xml…